vacancies

Troikaa is a young and fast growing system oriented pharmaceutical company. Troikaa is recognized as a discovery company, manufacturing innovative products based on varied Novel Drug Delivery Systems. The company has developed through in-house R&D, unique patented technology platforms for intra-oral, parenteral, sustained release and topical drug delivery. All these innovations are backed by requisite clinical trials. The company has two state of the art manufacturing facilities in India. The plants are designed for approvals in regulated markets.

Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK MHRA etc. with a turnover of more than $2.5 billion dollars.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas' success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. Intas is currently ranked 10th in the Indian Pharma Market with 2.80% market share. (as per IMS Health India, Secondary Stockiest Audit (SSA), Nov 16, 2016 MAT).

The council was created under the Ladakh Autonomous Hill Development Council Act 1995, following demands of Ladakhi people to make Leh District a new Indian Union Territory because of its religious and cultural differences with the rest of Jammu and Kashmir. In October 1993, the Indian Union Government and the Jammu and Kashmir State Government agreed to grant Ladakh the status of Autonomous Hill Council. The council came into being with the holding of elections on 28 August 1995

Post : Pharmacist

Ahmedabad District Health Society invites application for the post of Pharmacist on 11 months contractual basic.

Post : Pharmacist

The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October 1933 by the University of Mumbai, through active support of industries and philanthropists. The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs. The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted into an Institute on 26th January 2002. Under the World Bank TEQIP programme, the Maharashtra government granted it full autonomy in June 2004.

HITS has proudly established its health professional course that links health sciences and chemical sciences in 2005. The rapid growth of population demands better health care facilities and innovative research studies in pharmaceutical and bio-tech industry. As there is unprecedent demand for pharmacist’s today VPR has taken a forward step and started college of pharmacy which produced University top rankers and gold medalists.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.